Home/InMed Pharmaceuticals/Alexandra D.J. Mancini
AD

Alexandra D.J. Mancini

Senior Vice President, Clinical & Regulatory Affairs

InMed Pharmaceuticals

Therapeutic Areas

InMed Pharmaceuticals Pipeline

DrugIndicationPhase
INM-755Epidermolysis Bullosa (wound care)Phase 2
INM-088GlaucomaPreclinical